<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Gribnau, J.H.</title>
    <link>http://repub.eur.nl/res/aut/4014/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Different flavors of X-chromosome inactivation in mammals (Article)</title>
      <link>http://repub.eur.nl/res/pub/39814/</link>
      <pubDate>2013-04-09T00:00:00Z</pubDate>
      <description>Dosage compensation of X-linked gene products between the sexes in therians has culminated in the inactivation of one of the two X chromosomes in female cells. Over the years, the mouse has been the preferred animal model to study this X-chromosome inactivation (XCI) process in placental mammals (eutherians). Similar to the imprinted inactivation of the paternally inherited X chromosome (Xp) in marsupials (methatherians), the Xp is inactivated during early mouse development. In this eutherian model, cell derivatives of the primitive endoderm (PE) and trophectoderm (TE) will continue to display this imprinted form of XCI. Cells developing from the mouse epiblast will reactivate the Xp, and subsequently initiate XCI of either the Xp or the maternally inherited Xm, in a random manner. Examination of XCI in other eutherians and in metatherians, however, indicates clear differences in the form and timing of XCI. This review highlights and discusses imprinted and random XCI from such a comparative viewpoint. </description>
    </item> <item>
      <title>The Pluripotency Factor-Bound Intron 1 of Xist Is Dispensable for X Chromosome Inactivation and Reactivation In Vitro and In Vivo (Article)</title>
      <link>http://repub.eur.nl/res/pub/39381/</link>
      <pubDate>2013-03-22T00:00:00Z</pubDate>
      <description>X chromosome inactivation (XCI) is a dynamically regulated developmental process with inactivation and reactivation accompanying the loss and gain of pluripotency, respectively. A functional relationship between pluripotency and lack of XCI has been suggested, whereby pluripotency transcription factors repress the master regulator of XCI, the noncoding transcript Xist, by binding to its first intron (intron 1). To test this model, we have generated intron 1 mutant embryonic stem cells (ESCs) and two independent mouse models. We found that Xist's repression in ESCs, its transcriptional upregulation upon differentiation, and its silencing upon reprogramming to pluripotency are not dependent on intron 1. Although we observed subtle effects of intron 1 deletion on the randomness of XCI and in the absence of the antisense transcript Tsix in differentiating ESCs, these have little relevance in vivo because mutant mice do not deviate from Mendelian ratios of allele transmission. Altogether, our findings demonstrate that intron 1 is dispensable for the developmental dynamics of Xist expression. Video Abstract: . Display Omitted. </description>
    </item> <item>
      <title>Precise BAC targeting of genetically polymorphic mouse ES cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/33830/</link>
      <pubDate>2011-10-01T00:00:00Z</pubDate>
      <description>The use of bacterial artificial chromosomes (BACs) provides a consistent and high targeting efficiency of homologous recombination in embryonic stem (ES) cells, facilitated by long stretches of sequence homology. Here, we introduce a BAC targeting method which employs restriction fragment length polymorphisms (RFLPs) in targeted polymorphic C57BL/6/Cast/Ei F1 mouse ES cell lines to identify properly targeted ES cell clones. We demonstrate that knockout alleles can be generated either by targeting of an RFLP located in the open reading frame thereby disrupting the RFLP and ablating gene function, or by introduction of a transcription stop cassette that prematurely stops transcription of an RFLP located downstream of the stop cassette. With both methods we have generated Rnf12 heterozygous knockout ES cells, which were identified by allele specific PCR using genomic DNA or cDNA as a template. Our results indicate that this novel strategy is efficient and precise, by combining a high targeting efficiency with a convenient PCR based readout and reliable detection of correct targeting events. </description>
    </item> <item>
      <title>The inactive X chromosome adopts a unique three-dimensional conformation that is dependent on Xist RNA (Article)</title>
      <link>http://repub.eur.nl/res/pub/33955/</link>
      <pubDate>2011-07-01T00:00:00Z</pubDate>
      <description>Three-dimensional topology of DNA in the cell nucleus provides a level of transcription regulation beyond the sequence of the linear DNA. To study the relationship between the transcriptional activity and the spatial environment of a gene, we used allele-specific chromosome conformation capture-on-chip (4C) technology to produce high-resolution topology maps of the active and inactive X chromosomes in female cells. We found that loci on the active X form multiple long-range interactions, with spatial segregation of active and inactive chromatin. On the inactive X, silenced loci lack preferred interactions, suggesting a unique random organization inside the inactive territory. However, escapees, among which is Xist, are engaged in long-range contacts with each other, enabling identification of novel escapees. Deletion of Xist results in partial refolding of the inactive X into a conformation resembling the active X without affecting gene silencing or DNA methylation. Our data point to a role for Xist RNA in shaping the conformation of the inactive X chromosome at least partially independent of transcription. </description>
    </item> <item>
      <title>Xist regulation and function eXplored (Article)</title>
      <link>http://repub.eur.nl/res/pub/24037/</link>
      <pubDate>2011-05-31T00:00:00Z</pubDate>
      <description>X chromosome inactivation (XCI) is a process in mammals that ensures equal transcript levels between males and females by genetic inactivation of one of the two X chromosomes in females. Central to XCI is the long non-coding RNA Xist, which is highly and specifically expressed from the inactive X chromosome. Xist covers the X chromosome in cis and triggers genetic silencing, but its working mechanism remains elusive. Here, we review current knowledge about Xist regulation, structure, function and conservation and speculate on possible mechanisms by which its action is restricted in cis. We also discuss dosage compensation mechanisms other than XCI and how knowledge from invertebrate species may help to provide a better understanding of the mechanisms of mammalian XCI. </description>
    </item> <item>
      <title>RNF12 activates Xist and is essential for X chromosome inactivation (Article)</title>
      <link>http://repub.eur.nl/res/pub/22817/</link>
      <pubDate>2011-02-15T00:00:00Z</pubDate>
      <description>In somatic cells of female placental mammals, one of the two X chromosomes is transcriptionally silenced to accomplish an equal dose of X-encoded gene products in males and females. Initiation of random X chromosome inactivation (XCI) is thought to be regulated by X-encoded activators and autosomally encoded suppressors controlling Xist. Spreading of Xist RNA leads to silencing of the X chromosome in cis. Here, we demonstrate that the dose dependent X-encoded XCI activator RNF12/RLIM acts in trans and activates Xist. We did not find evidence for RNF12-mediated regulation of XCI through Tsix or the Xist intron 1 region, which are both known to be involved in inhibition of Xist. In addition, we found that Xist intron 1, which contains a pluripotency factor binding site, is not required for suppression of Xist in undifferentiated ES cells. Analysis of female Rnf12-/- knockout ES cells showed that RNF12 is essential for initiation of XCI and is mainly involved in the regulation of Xist. We conclude that RNF12 is an indispensable factor in up-regulation of Xist transcription, thereby leading to initiation of random XCI.</description>
    </item> <item>
      <title>RNF12 activates Xist and is essential for X chromosome inactivation (Article)</title>
      <link>http://repub.eur.nl/res/pub/23995/</link>
      <pubDate>2011-02-15T00:00:00Z</pubDate>
      <description>In somatic cells of female placental mammals, one of the two X chromosomes is transcriptionally silenced to accomplish an equal dose of X-encoded gene products in males and females. Initiation of random X chromosome inactivation (XCI) is thought to be regulated by X-encoded activators and autosomally encoded suppressors controlling Xist. Spreading of Xist RNA leads to silencing of the X chromosome in cis. Here, we demonstrate that the dose dependent X-encoded XCI activator RNF12/RLIM acts in trans and activates Xist. We did not find evidence for RNF12-mediated regulation of XCI through Tsix or the Xist intron 1 region, which are both known to be involved in inhibition of Xist. In addition, we found that Xist intron 1, which contains a pluripotency factor binding site, is not required for suppression of Xist in undifferentiated ES cells. Analysis of female Rnf12-/-knockout ES cells showed that RNF12 is essential for initiation of XCI and is mainly involved in the regulation of Xist. We conclude that RNF12 is an indispensable factor in up-regulation of Xist transcription, thereby leading to initiation of random XCI. </description>
    </item> <item>
      <title>Evaluating the relationship between spermatogenic silencing of the X chromosome and evolution of the Y chromosome in chimpanzee and human (Article)</title>
      <link>http://repub.eur.nl/res/pub/28727/</link>
      <pubDate>2010-12-01T00:00:00Z</pubDate>
      <description>Chimpanzees and humans are genetically very similar, with the striking exception of their Y chromosomes, which have diverged tremendously. The male-specific region (MSY), representing the greater part of the Y chromosome, is inherited from father to son in a clonal fashion, with natural selection acting on the MSY as a unit. Positive selection might involve the performance of the MSY in spermatogenesis. Chimpanzees have a highly polygamous mating behavior, so that sperm competition is thought to provide a strong selective force acting on the Y chromosome in the chimpanzee lineage. In consequence of evolution of the heterologous sex chromosomes in mammals, meiotic sex chromosome inactivation (MSCI) results in a transcriptionally silenced XY body in male meiotic prophase, and subsequently also in postmeiotic repression of the sex chromosomes in haploid spermatids. This has evolved to a situation where MSCI has become a prerequisite for spermatogenesis. Here, by analysis of microarray testicular expression data representing a small number of male chimpanzees and men, we obtained information indicating that meiotic and postmeiotic X chromosome silencing might be more effective in chimpanzee than in human spermatogenesis. From this, we suggest that the remarkable reorganization of the chimpanzee Y chromosome, compared to the human Y chromosome, might have an impact on its meiotic interactions with the X chromosome and thereby on X chromosome silencing in spermatogenesis. Further studies will be required to address comparative functional aspects of MSCI in chimpanzee, human, and other placental mammals. </description>
    </item> <item>
      <title>A key commitment step in erythropoiesis is synchronized with the cell cycle clock through mutual inhibition between PU.1 and S-phase progression (Article)</title>
      <link>http://repub.eur.nl/res/pub/21357/</link>
      <pubDate>2010-09-01T00:00:00Z</pubDate>
      <description>Hematopoietic progenitors undergo differentiation while navigating several cell division cycles, but it is unknown whether these two processes are coupled. We addressed this question by studying erythropoiesis in mouse fetal liver in vivo. We found that the initial upregulation of cell surface CD71 identifies developmentally matched erythroblasts that are tightly synchronized in S-phase. We show that DNA replication within this but not subsequent cycles is required for a differentiation switch comprising rapid and simultaneous committal transitions whose precise timing was previously unknown. These include the onset of erythropoietin dependence, activation of the erythroid master transcriptional regulator GATA-1, and a switch to an active chromatin conformation at the β-globin locus. Specifically, S-phase progression is required for the formation of DNase I hypersensitive sites and for DNA demethylation at this locus. Mechanistically, we show that S-phase progression during this key committal step is dependent on downregulation of the cyclin-dependent kinase p57KIP2 and in turn causes the downregulation of PU.1, an antagonist of GATA-1 function. These findings therefore highlight a novel role for a cyclin-dependent kinase inhibitor in differentiation, distinct to their known function in cell cycle exit. Furthermore, we show that a novel, mutual inhibition between PU.1 expression and S-phase progression provides a "synchromesh" mechanism that "locks" the erythroid differentiation program to the cell cycle clock, ensuring precise coordination of critical differentiation events.</description>
    </item> <item>
      <title>A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/28684/</link>
      <pubDate>2010-06-04T00:00:00Z</pubDate>
      <description>Murine pluripotent stem cells can exist in two functionally distinct states, LIF-dependent embryonic stem cells (ESCs) and bFGF-dependent epiblast stem cells (EpiSCs). However, human pluripotent cells so far seemed to assume only an epiblast-like state. Here we demonstrate that human iPSC reprogramming in the presence of LIF yields human stem cells that display morphological, molecular, and functional properties of murine ESCs. We termed these hLR5 iPSCs because they require the expression of five ectopic reprogramming factors, Oct4, Sox2, Klf4, cMyc, and Nanog, to maintain this more naive state. The cells are "metastable" and upon ectopic factor withdrawal they revert to standard human iPSCs. Finally, we demonstrate that the hLR5 state facilitates gene targeting, and as such provides a powerful tool for the generation of recombinant human pluripotent stem cell lines. </description>
    </item> <item>
      <title>X-changing information on X inactivation (Article)</title>
      <link>http://repub.eur.nl/res/pub/19398/</link>
      <pubDate>2010-03-10T00:00:00Z</pubDate>
      <description>In female somatic cells of mammalian species one X chromosome is inactivated to ensure dosage equality of X-encoded genes between females and males, during development and adulthood. X chromosome inactivation (XCI) involves various epigenetic mechanisms, including RNA mediated gene silencing in cis, DNA methylation, and changes in chromatin modifications and composition. XCI therefore provides an attractive paradigm to study epigenetic gene regulation in a more general context. The XCI process starts with counting of the number of X chromosomes present in a nucleus, and initiation of XCI follows if this number exceeds one per diploid genome. Recently, X-encoded RNF12 has been identified as a dose-dependent activator of XCI. In addition, other factors, including the pluripotency factors OCT4, SOX2 and Nanog, have been implicated to play a role in suppression of initiation of XCI. In this review, we highlight and explain these new and old findings in the context of a stochastic model for X chromosome counting and XCI initiation.</description>
    </item> <item>
      <title>RNF12 Is an X-Encoded Dose-Dependent Activator of X Chromosome Inactivation (Article)</title>
      <link>http://repub.eur.nl/res/pub/24304/</link>
      <pubDate>2009-11-25T00:00:00Z</pubDate>
      <description>In somatic cells of female placental mammals, one X chromosome is inactivated to minimize sex-related dosage differences of X-encoded genes. Random X chromosome inactivation (XCI) in the embryo is a stochastic process, in which each X has an independent probability to initiate XCI, triggered by the nuclear concentration of one or more X-encoded XCI-activators. Here, we identify the E3 ubiquitin ligase RNF12 as an important XCI-activator. Additional copies of mouse Rnf12 or human RNF12 result in initiation of XCI in male mouse ES cells and on both X chromosomes in a substantial percentage of female mouse ES cells. This activity is dependent on an intact open reading frame of Rnf12 and correlates with the transgenic expression level of RNF12. Initiation of XCI is markedly reduced in differentiating female heterozygous Rnf12+/-ES cells. These findings provide evidence for a dose-dependent role of RNF12 in the XCI counting and initiation process. </description>
    </item> <item>
      <title>X chromosome inactivation is initiated in human preimplantation embryos (Article)</title>
      <link>http://repub.eur.nl/res/pub/21002/</link>
      <pubDate>2009-06-01T00:00:00Z</pubDate>
      <description>X chromosome inactivation (XCI) is the mammalian mechanism that compensates for the difference in gene dosage between XX females and XY males. Genetic and epigenetic regulatory mechanisms induce transcriptional silencing of one X chromosome in female cells. In mouse embryos, XCI is initiated at the preimplantation stage following early whole-genome activation. It is widely thought that human embryos do not employ XCI prior to implantation. Here, we show that female preimplantation embryos have a progressive accumulation of XIST  RNA on one of the two X chromosomes, starting around the 8-cell stage. XIST  RNA accumulates at the morula and blastocyst stages and is associated with transcriptional silencing of the XIST-coated chromosomal region. These findings indicate that XCI is initiated in female human preimplantation-stage embryos and suggest that preimplantation dosage compensation is evolutionarily conserved in placental mammals.</description>
    </item> <item>
      <title>The probability to initiate X chromosome inactivation is determined by the X to autosomal ratio and X chromosome specific allelic properties (Article)</title>
      <link>http://repub.eur.nl/res/pub/16524/</link>
      <pubDate>2009-05-19T00:00:00Z</pubDate>
      <description>Background: In female mammalian cells, random X chromosome inactivation (XCI) equalizes the dosage of X-encoded gene products to that in male cells. XCI is a stochastic process, in which each X chromosome has a probability to be inactivated. To obtain more insight in the factors setting up this probability, we studied the role of the X to autosome (X:A) ratio in initiation of XCI, and have used the experimental data in a computer simulation model to study the cellular population dynamics of XCI. Methodology/Principal Findings: To obtain more insight in the role of the X:A ratio in initiation of XCI, we generated triploid mouse ES cells by fusion of haploid round spermatids with diploid female and male ES cells. These fusion experiments resulted in only XXY triploid ES cells. XYY and XXX ES lines were absent, suggesting cell death related either to insufficient X-chromosomal gene dosage (XYY) or to inheritance of an epigenetically modified X chromosome (XXX). Analysis of active (Xa) and inactive (Xi) X chromosomes in the obtained triploid XXY lines indicated that the initiation frequency of XCI is low, resulting in a mixed population of XaXiY and XaXaY cells, in which the XaXiY cells have a small proliferative advantage. This result, and findings on XCI in diploid and tetraploid ES cell lines with different X:A ratios, provides evidence that the X:A ratio determines the probability for a given X chromosome to be inactivated. Furthermore, we found that the kinetics of the XCI process can be simulated using a probability for an X chromosome to be inactivated that is proportional to the X:A ratio. These simulation studies re-emphasize our hypothesis that the probability is a function of the concentration of an X-encoded activator of XCI, and of X chromosome specific allelic properties determining the threshold for this activator. Conclusions: The present findings reveal that the probability for an X chromosome to be inactivated is proportional to the X:A ratio. This finding supports the presence of an X-encoded activator of the XCI process.</description>
    </item> <item>
      <title>CTCF regulates cell cycle progression of αβ T cells in the thymus (Article)</title>
      <link>http://repub.eur.nl/res/pub/29471/</link>
      <pubDate>2008-11-05T00:00:00Z</pubDate>
      <description>The 11-zinc finger protein CCCTC-binding factor (CTCF) is a highly conserved protein, involved in imprinting, long-range chromatin interactions and transcription. To investigate its function in vivo, we generated mice with a conditional Ctcf knockout allele. Consistent with a previous report, we find that ubiquitous ablation of the Ctcf gene results in early embryonic lethality. Tissue-specific inactivation of CTCF in thymocytes specifically hampers the differentiation of αβ T cells and causes accumulation of late double-negative and immature single-positive cells in the thymus of mice. These cells are normally large and actively cycling, and contain elevated amounts of CTCF. In Ctcf knockout animals, however, these cells are small and blocked in the cell cycle due to increased expression of the cyclin-CDK inhibitors p21 and p27. Taken together, our results show that CTCF is required in a dose-dependent manner and is involved in cell cycle progression of αβ T cells in the thymus. We propose that CTCF positively regulates cell growth in rapidly dividing thymocytes so that appropriate number of cells are generated before positive and negative selection in the thymus. </description>
    </item> <item>
      <title>Xist RNA is confined to the nuclear territory of the silenced X chromosome throughout the cell cycle (Article)</title>
      <link>http://repub.eur.nl/res/pub/15202/</link>
      <pubDate>2008-09-01T00:00:00Z</pubDate>
      <description>In mammalian female cells, one X chromosome is inactivated to prevent a dose difference in the expression of X-encoded proteins between males and females. Xist RNA, required for X chromosome inactivation, is transcribed from the future inactivated X chromosome (Xi), where it spreads in cis, to initiate silencing. We have analyzed Xist RNA transcription and localization throughout the cell cycle. It was found that Xist transcription is constant and that the mature RNA remains attached to the Xi throughout mitosis. Diploid and tetraploid cell lines with an MS2-tagged Xist gene were used to investigate spreading of Xist. Most XXXXMS2 tetraploid mouse embryonic stem (ES) cells inactivate the XMS2 chromosome and one other X chromosome. Analysis of cells with two Xi's indicates that Xist RNA is retained by the Xi of its origin and does not spread in trans. Also, in XXMS2 diploid mouse ES cells with an autosomal Xist transgene, there is no trans exchange of Xist RNA from the Xi to the autosome. We propose that Xist RNA does not dissociate from the Xi of its origin, which precludes a model of diffusion-mediated trans spreading of Xist RNA.</description>
    </item> <item>
      <title>X Inactivation Counting and Choice Is a Stochastic Process: Evidence for Involvement of an X-Linked Activator (Article)</title>
      <link>http://repub.eur.nl/res/pub/28982/</link>
      <pubDate>2008-02-08T00:00:00Z</pubDate>
      <description>Female mammalian cells achieve dosage compensation of X-encoded genes by X chromosome inactivation (XCI). This process is thought to involve X chromosome counting and choice. To explore how this process is initiated, we analyzed XCI in tetraploid XXXX, XXXY, and XXYY embryonic stem cells and found that every X chromosome within a single nucleus has an independent probability to initiate XCI. This finding suggests a stochastic mechanism directing XCI counting and choice. The probability is directly proportional to the X chromosome:ploidy ratio, indicating the presence of an X-encoded activator of XCI, that itself is inactivated by the XCI process. Deletion of a region including Xist, Tsix, and Xite still results in XCI on the remaining wild-type X chromosome in female cells. This result supports a stochastic model in which each X chromosome in a nucleus initiates XCI independently and positions an X-encoded trans-acting XCI-activator outside the deleted region. </description>
    </item> <item>
      <title>X inactivation Xplained (Article)</title>
      <link>http://repub.eur.nl/res/pub/36383/</link>
      <pubDate>2007-10-01T00:00:00Z</pubDate>
      <description>Random inactivation of one of the two female X chromosomes establishes dosage compensation between XY males and XX females in placental mammals. X inactivation is controlled by the X inactivation center (Xic). Recent advances in genome sequencing show that the Xic has evolved from an ancestral vertebrate gene cluster in placental mammals and has undergone separate rearrangements in marsupials. The Xic ensures that all but one X chromosome per diploid genome are inactivated. Which chromosome remains active is randomly chosen. Pairing of Xic loci on the two X chromosomes and alternate states of the X chromosomes before inactivation have recently been implicated in the mechanism of random choice. Chromosome-wide silencing is then initiated by the noncoding Xist RNA, which evolved with the mammalian Xic and covers the inactive X chromosome. </description>
    </item> <item>
      <title>The role of the -50 region of the human gamma-globin gene in switching. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12952/</link>
      <pubDate>2001-09-17T00:00:00Z</pubDate>
      <description>During the switch from human gamma- (fetal) to beta- (adult) globin gene
      expression, the gamma and beta genes are expressed competitively by an
      alternating transcription mechanism. The -50 region of the gamma gene
      promoter has been proposed to be responsible for the early competitive
      advantage of the gamma genes and to act as a stage selector element (SSE)
      in hemoglobin switching. We analyzed the effect of mutating the -50 region
      of the gamma gene in the presence of a competing beta gene in transgenic
      mice. This shows that the -50 region does not affect silencing of the beta
      gene in early development and does not act as a stage selector. However,
      it affects the ratio of gamma versus beta gene expression in the early,
      but not later, stages of fetal development. Interestingly, both the
      wild-type and mutant minilocus constructs show a higher frequency of
      alternate transcription than observed in the complete locus, suggesting
      that sequences normally present between the gamma and beta genes
      facilitate the interaction of the locus control region (LCR) and
      beta-globin gene in the complete locus.</description>
    </item> <item>
      <title>An intrinsic but cell-nonautonomous defect in GATA-1 overexpressing mouse erythroid cells. (Letter To Editor)</title>
      <link>http://repub.eur.nl/res/pub/2589/</link>
      <pubDate>2000-08-03T00:00:00Z</pubDate>
      <description>GATA-1 is a tissue-specific transcription factor that is essential for the production of red blood cells. Here we show that overexpression of GATA-1 in erythroid cells inhibits their differentiation, leading to a lethal anaemia. Using chromosome-X-inactivation of a GATA-1 transgene and chimaeric animals, we show that this defect is intrinsic to erythroid cells, but nevertheless cell nonautonomous. Usually, cell nonautonomy is thought to reflect aberrant gene function in cells other than those that exhibit the phenotype. On the basis of our data, we propose an alternative mechanism in which a signal originating from wild-type erythroid cells restores normal differentiation to cells overexpressing GATA-1 in vivo. The existence of such a signalling mechanism indicates that previous interpretations of cell-nonautonomous defects may be erroneous in some cases and may in fact assign gene function to incorrect cell types.</description>
    </item> <item>
      <title>ß-globin gene regulation and chromatin structure (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/19995/</link>
      <pubDate>1999-06-30T00:00:00Z</pubDate>
      <description>Oxygen transport in the blood is mediated by highly specialized red cells. The
majority of the proteins of a red cell comprises the oxygen carrier protein
hemoglobin, which is a hetero-tctrameric protein that consists of two a and two p
globin chains. In humans different u- and p-like globin chains are expressed during
development resulting in several different hemoglobin tetramers. The expression of
different globin chains serves to facilitate the oxygen uptake by the emblYo, since
embryonic hemoglobin has a higher affinity for oxygen. The genes that code for the
u- and p-like globin chains reside in loci located on separate chromosomes. Many
blood disorders, like u- and p-thalassemias and sickle cell anemia are the
consequence of deletions or mutations of sequences in these loci and they initiated
extensive research into the molecular basis of these diseases. Especially the p globin
locus has served as a model system to study the regulation of multi gene loci. The
five functional globin genes, 5'-s_Gy_Ay-o-P-3', are differentially expressed during
development. Proper expression of these genes requires the presence of a region
located 5' upstream of the s globin gene. This locus control region (LCR) contains 5
small regions that bind several trans-acting factors in an erythroid environment. The
aim of this thesis is to study the role of the LCR in the regulation of the ~ globin
genes ill vivo.
Chapter 1 reviews the CUlTent knowledge in the regnlation of eukaryotic
transcription and chromatin. Chapter 2 gives a broad introduction covering two
decades of shldies conceming the regulation of the human and murine p globin genes
and serves as an outline for the results that wiII be discussed in the chapters 3 to 6.
Chapter 3 describes the role of EKLF in the y to p globin switching process.
Chapter 4 and 5 describe experiments that show that the human and the murine LCR
can only activate one globin gene at a given moment. Chapter 6 describes the
characterization of intergenic transcription in the human p globin locus. Finally in
chapter 7 the implications of the results presented in this thesis will be discussed.</description>
    </item> <item>
      <title>Mechanisms of developmental control of transcription in the murine alpha- and beta-globin loci (Article)</title>
      <link>http://repub.eur.nl/res/pub/8997/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>We have characterized mRNA expression and transcription of the mouse
          alpha- and beta-globin loci during development. S1 nuclease and primary
          transcript in situ hybridization analyses demonstrate that all seven
          murine globin genes (zeta, alpha1, alpha2, epsilony, betaH1, betamaj, and
          betamin) are transcribed during primitive erythropoiesis, however
          transcription of the zeta, epsilony, and betaH1 genes is restricted to the
          primitive erythroid lineage. Transcription of the betamaj and betamin
          genes in primitive cells is EKLF-dependent demonstrating EKLF activity in
          embryonic red cells. Novel kinetic analyses suggest that multigene
          expression in the beta locus occurs via alternating single-gene
          transcription whereas coinitiation cannot be ruled out in the alpha locus.
          Transcriptional activation of the individual murine beta genes in
          primitive cells correlates inversely with their distance from the locus
          control region, in contrast with the human beta locus in which the adult
          genes are only activated in definitive erythroid cells. The results
          suggest that the multigene expression mechanism of alternating
          transcription is evolutionarily conserved between mouse and human beta
          globin loci but that the timing of activation of the adult genes is
          altered, indicating important fundamental differences in globin gene
          switching.</description>
    </item> <item>
      <title>Chromatin interaction mechanism of transcriptional control in vivo. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12805/</link>
      <pubDate>1998-10-15T00:00:00Z</pubDate>
      <description>We have used a kinetic analysis to distinguish possible mechanisms of
          activation of transcription of the different genes in the human beta
          globin locus. Based on in situ studies at the single-cell level we have
          previously suggested a dynamic mechanism of single genes alternately
          interacting with the locus control region (LCR) to activate transcription.
          However, those steady-state experiments did not allow a direct measurement
          of the dynamics of the mechanism and the presence of loci with in situ
          primary transcript signals from two beta-like genes in cis has left open
          the possibility that multiple genes in the locus could initiate
          transcription simultaneously. Kinetic assays involving removal of a block
          to transcription elongation in conjunction with RNA FISH show that
          multiple beta gene primary transcript signals in cis represent a
          transition between alternating transcriptional periods of single genes,
          supporting a dynamic interaction mechanism.</description>
    </item> <item>
      <title>The role of EKLF in human β-globin gene competition. (Article)</title>
      <link>http://repub.eur.nl/res/pub/2540/</link>
      <pubDate>1996-01-01T00:00:00Z</pubDate>
      <description>We have investigated the role of erythroid Kruppel-like factor (EKLF) in expression of the human beta-globin genes in compound EKLF knockout/human beta-locus transgenic mice. EKLF affects only the adult mouse beta-globin genes in homozygous knockout mice; heterozygous mice are unaffected. Here we show that EKLF knockout mice express the human epsilon and gamma-globin genes normally in embryonic red cells. However, fetal liver erythropoiesis, which is marked by a period of gamma- and beta-gene competition in which the genes are alternately transcribed, exhibits an altered ratio of gamma- to beta-gene transcription. EKLF heterozygous fetal livers display a decrease in the number of transcriptionally active beta genes with a reciprocal increase in the number of transcriptionally active gamma genes. beta-Gene transcription is absent in homozygous knockout fetuses with coincident changes in chromatin structure at the beta promoter. There is a further increase in the number of transcriptionally active gamma genes and accompanying gamma gene promoter chromatin alterations. These results indicate that EKLF plays a major role in gamma- and beta-gene competition and suggest that EKLF is important in stabilizing the interaction between the Locus Control Region and the beta-globin gene. In addition, these findings provide further evidence that developmental modulation of globin gene expression within individual cells is accomplished by altering the frequency and/or duration of transcriptional periods of a gene rather than changing the rate of transcription.</description>
    </item>
  </channel>
</rss>